Results 341 to 350 of about 932,842 (376)

The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?

Dermatology, 2021
Background: Dermatophytosis is commonly encountered in the dermatological clinics. The main aetiological agents in dermatophytosis of skin and nails in humans are Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale (former T.
Julia J. Shen, M. Arendrup, S. Verma, D. Saunte   +3 more
semanticscholar   +1 more source

Antifungal Susceptibility Testing and Identification

Infectious Disease Clinics of North America, 2021
The requirement for antifungal susceptibility testing is increasing given the availability of new drugs, increasing populations of individuals at risk for fungal infection, and emerging multiresistant fungi. Rapid and accurate fungal identification remains at the forefront of laboratory efforts to guide empiric therapy.
Catriona Halliday, Lucy C. Crawford, Sarah E. Kidd   +2 more
openaire   +2 more sources

Antifungal Susceptibility Testing

Infectious Disease Clinics of North America, 2006
Antifungal susceptibility testing has been in routine use now for more than 15 years and has become a useful tool for clinicians who are faced with difficult treatment decision. Although most clinicians order susceptibility testing, much confusion still exists regarding the use of the results.
Annette W. Fothergill, Deanna A. Sutton, Michael G. Rinaldi, Michael G. Rinaldi   +3 more
openaire   +2 more sources

Antifungal susceptibility testing of dermatophytes: Development and evaluation of an optimised broth microdilution method

Mycoses (Berlin), 2020
Dermatophytosis is one of the most common infections affecting 3%–17% of the population. Resistance to antifungals so far was not of concern in the therapeutic management.
Riccardo Curatolo, N. Juricevic, C. Leong, P. Bosshard   +3 more
semanticscholar   +1 more source

In Vitro Antifungal Susceptibility Testing

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
With the rising frequency of fungal infections, as well as increasing reports of resistance to antifungal agents, it is imperative that clinically applicable antifungal susceptibility testing be available. In 1997 the National Committee for Clinical Laboratory Standards published standard guidelines for antifungal susceptibility testing of Candida sp ...
Michael A. Pfaller, Holly L. Hoffman
openaire   +3 more sources

Antifungal Agents and Antifungal Susceptibility Testing

2010
1 Systemic Antifungal Drugs in Current Use 2 Future Antifungal Drugs 3 Antifungal Susceptibility Testing 4 Methods of Susceptibility Testing Keywords: antifungal agents and antifungal susceptibility testing; systemic antifungal drugs in current use; antifungal mechanisms of action; lipid vehicles for polyenes; unique ...
John R. Graybill, Sanjay G. Revankar, Sanjay G. Revankar, Thomas F. Patterson   +3 more
openaire   +2 more sources

Antifungal Susceptibility Testing in Teaching Hospitals

Annals of Pharmacotherapy, 2003
BACKGROUND: An assessment of antifungal susceptibility testing (AST) has not been conducted since the introduction of the National Committee for Clinical Laboratory Standards (NCCLS) M27-A document. OBJECTIVE: To determine AST practices in teaching hospitals.
Susan L. Pendland, Manjunath P. Pai
openaire   +3 more sources

Antifungal susceptibility testing with dermatophytes

Mycoses, 1991
Summary. The determination of the in vitro activity of antimycotics against dermatophytes has for long been considered as irrelevant from a practical point of view. Recently, however, this approach has been questioned. Various different tests such as agar diffusion test, agar dilution test and broth dilution test can be used for the determination of ...
Hans Christian Korting, Aletta Georgii
openaire   +3 more sources